Bill to Expand Cannabinoid Research Goes to President
On November 16, 2022, the U.S. Senate approved the House-passed bipartisan Medical Marijuana and Cannabidiol…
Browsing: Federal
Medicare Coverage of Telehealth Services in 2023
On November 01, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a rule…
Aimed Alliance Featured in Leaders Edge
On November 11, Aimed Alliance was featured in Leader’s Edge. Leader’s Edge is an award-winning content…
Aimed Alliance Hosts Discussion on Step Therapy Reform in New York
On October 17, 2022, the New York Step Therapy Alliance hosted a roundtable meeting to…
Aimed Alliance Urges Senators to Expand Access to Treatments for OUD
On November 2, 2022, Aimed Alliance hosted a legislative briefing on facilitating access to medications…
FDA Issues Warning to CBD Manufacturer
The U.S. Food and Drug Administration (FDA) has issued a warning letter to a company…
Upcoming Webinar: Essential Health Benefits, Importation, and More – Do You Know the Risks?
Join Aimed Alliance for a Free HR.com Webinar: Essential Health Benefits, Importation, and More –…
Upcoming Webinar: Cannabis, CBD, and Cannabinoids: What Employers and Consumers Should Know
Join Aimed Alliance for a Free Advocacy Briefing on Cannabis, CBD, and Cannabinoids: What Employers…
Aimed Alliance Releases Updated Open Enrollment Brochures
The open enrollment periods for individual, small, large group, and Medicare plans have recently opened…
Upcoming Advocacy Briefing: S.3257 Facilitating Access to MOUD Treatments
Join Aimed Alliance for a Free Advocacy Briefing on S.3257 to Facilitate Access to Medication…